156 related articles for article (PubMed ID: 12219875)
21. Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway.
Moreno L; Losada B; Cogolludo Al; Lodi F; Lugnier C; Villamor E; Moro M; Tamargo J; Pérez-Vizcaíno F
Pediatr Res; 2004 Oct; 56(4):563-70. PubMed ID: 15295092
[TBL] [Abstract][Full Text] [Related]
22. Combination of phentolamine and L-arginine or sildenafil synergistically improves neurogenic relaxation of rabbit corpus cavernosum smooth muscle.
Angulo J; Cuevas P; Fernández A; Gabancho S; Saenz de Tejada I
Urology; 2001 Mar; 57(3):585-9. PubMed ID: 11248652
[TBL] [Abstract][Full Text] [Related]
23. Sildenafil (Viagra) augments sodium nitroprusside-induced but not nitroglycerin-induced hypotension in dogs.
Yoo KY; Kim HS; Moon JD; Lee J
Anesth Analg; 2002 Jun; 94(6):1505-9, table of contents. PubMed ID: 12032016
[TBL] [Abstract][Full Text] [Related]
24. Changed phosphodiesterase selectivity and enhanced in vitro efficacy by selective deuteration of sildenafil.
Schneider F; Mattern-Dogru E; Hillgenberg M; Alken RG
Arzneimittelforschung; 2007; 57(6):293-8. PubMed ID: 17688073
[TBL] [Abstract][Full Text] [Related]
25. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
Ferreira-Melo SE; Yugar-Toledo JC; Coelho OR; De Luca IM; Tanus-Santos JE; Hyslop S; Irigoyen MC; Moreno H
Eur J Pharmacol; 2006 Aug; 542(1-3):141-7. PubMed ID: 16806160
[TBL] [Abstract][Full Text] [Related]
26. Effect of sildenafil on the isolated rat aortic rings.
Sharabi FM; Daabees TT; El-Metwally MA; Senbel AM
Fundam Clin Pharmacol; 2005 Aug; 19(4):449-56. PubMed ID: 16011732
[TBL] [Abstract][Full Text] [Related]
27. Effect of sildenafil on coronary active and reactive hyperemia.
Chen Y; Du R; Traverse JH; Bache RJ
Am J Physiol Heart Circ Physiol; 2000 Nov; 279(5):H2319-25. PubMed ID: 11045968
[TBL] [Abstract][Full Text] [Related]
28. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage.
Rodríguez-Iturbe B; Ferrebuz A; Vanegas V; Quiroz Y; Espinoza F; Pons H; Vaziri ND
Kidney Int; 2005 Nov; 68(5):2131-42. PubMed ID: 16221212
[TBL] [Abstract][Full Text] [Related]
29. The pharmacology of sildenafil, a novel and selective inhibitor of phosphodiesterase (PDE) type 5.
Wallis RM
Nihon Yakurigaku Zasshi; 1999 Oct; 114 Suppl 1():22P-26P. PubMed ID: 10629850
[TBL] [Abstract][Full Text] [Related]
30. Cyclic GMP phosphodiesterase-5: target of sildenafil.
Corbin JD; Francis SH
J Biol Chem; 1999 May; 274(20):13729-32. PubMed ID: 10318772
[No Abstract] [Full Text] [Related]
31. Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery.
Pauvert O; Lugnier C; Keravis T; Marthan R; Rousseau E; Savineau JP
Br J Pharmacol; 2003 Jun; 139(3):513-22. PubMed ID: 12788811
[TBL] [Abstract][Full Text] [Related]
32. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal.
Atz AM; Wessel DL
Anesthesiology; 1999 Jul; 91(1):307-10. PubMed ID: 10422958
[No Abstract] [Full Text] [Related]
33. Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients.
Attinà TM; Malatino LS; Maxwell SR; Padfield PL; Webb DJ
J Hypertens; 2008 Mar; 26(3):501-7. PubMed ID: 18300861
[TBL] [Abstract][Full Text] [Related]
34. The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues.
Aziz MT; Mostafa T; Atta H; Rashed L; Marzouk SA; Obaia EM; Sabry D; Hassouna AA; El-Shehaby AM; Aziz AT
J Sex Med; 2008 Jul; 5(7):1636-45. PubMed ID: 18208506
[TBL] [Abstract][Full Text] [Related]
35. The effect of Sildenafil on human platelet secretory function is controlled by a complex interplay between phosphodiesterases 2, 3 and 5.
Dunkern TR; Hatzelmann A
Cell Signal; 2005 Mar; 17(3):331-9. PubMed ID: 15567064
[TBL] [Abstract][Full Text] [Related]
36. cGMP-phosphodiesterase antagonists inhibit Ca2+-influx in Dictyostelium discoideum and bovine cyclic-nucleotide-gated-channel.
Lusche DF; Kaneko H; Malchow D
Eur J Pharmacol; 2005 Apr; 513(1-2):9-20. PubMed ID: 15878705
[TBL] [Abstract][Full Text] [Related]
37. Effects and mechanisms of action of sildenafil citrate in human chorionic arteries.
Maharaj CH; O'Toole D; Lynch T; Carney J; Jarman J; Higgins BD; Morrison JJ; Laffey JG
Reprod Biol Endocrinol; 2009 Apr; 7():34. PubMed ID: 19389232
[TBL] [Abstract][Full Text] [Related]
38. Effects of sildenafil on retinal blood flow and flicker-induced retinal vasodilatation in healthy subjects.
Polak K; Wimpissinger B; Berisha F; Georgopoulos M; Schmetterer L
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4872-6. PubMed ID: 14578411
[TBL] [Abstract][Full Text] [Related]
39. Peripheral and central activation of nitric oxide-cyclic GMP pathway by sildenafil.
Patil CS; Singh VP; Kulkarni SK
Inflammopharmacology; 2005; 13(5-6):467-78. PubMed ID: 16280099
[TBL] [Abstract][Full Text] [Related]
40. The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway.
Riazi K; Roshanpour M; Rafiei-Tabatabaei N; Homayoun H; Ebrahimi F; Dehpour AR
Br J Pharmacol; 2006 Apr; 147(8):935-43. PubMed ID: 16474413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
